Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |